Leadership Team

ASSESS has been created by a Leadership Team with deep experience in life sciences technology evaluation and commercialization.


Dr. Christopher McCabe

Co-Founder & Chief Scientific Officer (CSO)
Dr. Christopher McCabe is the originator of the Value Engineered Translation framework that underpins much of the service offerings. Dr. McCabe has overall responsibility for product content and quality assurance (QA). Part of his QA portfolio includes the recruitment and accreditation of analysts and experts who undertake service delivery. He also leads the development of new products. Dr. McCabe is the lead for Business Development in the UK and EU markets.

Concurrent with his role at ASSESS, Professor McCabe has lead responsibility for Queens University Belfast’s Belfast Region City Deal Programme. Powered by over £170 million of investment from the UK government, the programme will deliver Innovation Centres in Deep Tech, Advanced Manufacturing and the Life Sciences, to create jobs and drive inclusive economic growth across Northern Ireland. Previously, he was the CEO of the Institute of Health Economics in Alberta, Canada, and Professor of Health Economics at the University of Alberta.

He has 30 years experience as a health economist working in the area of economic evaluation and health technology assessment. He has contributed to several standard setting documents related to the evaluation of innovative health technologies both nationally and internationally, including the second edition of the NICE Guide to the Methods of Health Technology Appraisal, the fourth edition of the CADTH Guidelines for the Economic Evaluation of Health Technologies, and third edition of the ISSC Guidelines for the translation of stem cell research and regenerative medicine. He has been an expert witness to both the UK and Canadian House of Commons Health committees and recently advised Canada’s Patented Medicines Price Review Board on the development of Value Based Pricing for patented drugs in Canada.


Dan Palfrey

Co-Founder & Chief Partnership Officer (CPO)
Dan Palfrey leads strategic development, partnerships, program development, and oversees the delivery of all business functions. Dan is leading Business Development in North American markets.

Previously, he was Director of Industry Partnerships at the Institute of Health Economics, a research institute located in Alberta, Canada. Following completion of a Master of Public Health degree from the University of Alberta, Dan began his career in the pharmaceutical industry, holding progressive leadership positions in Commercial and Government Relations roles. He then served as Vice President, Commercialization, for what became one of Canada’s leading electronic medical record companies. He led the company from early growth to acquisition by one of Canada’s largest corporations. He is Board member of The Health Data Coalition, and past Board Member of the Canadian Association for Population Therapeutics, and an Advisor to a number of organizations in the health innovation ecosystem.


Bryan Grunow

Co-Founder & Chief Technology Officer (CTO)
Bryan Grunow leads design, development, and delivery of the ASSESS platform worldwide. He is 24-year software industry veteran who has worked across the software landscape from low-level software design and development to leading engineering units (development, test, performance engineering, and operations) to design, deploy, and manage next generation cloud platforms.

Contact Us

Contact us to learn more about how insights from ASSESS can help your organization to inform investor decision-making and improve valuation and probability of capital raise success.

Let's talk